CClinicalTrials.gg
CompletedNCT07030608Updated Aug 3, 2025

The Effect Of Pelvic Floor Muscle Exercises On Sexual Life In Women With Overactive Bladder

An interventional study of Exercise in Sexual Function and Over Active Bladder, sponsored by Biruni University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-08-03.

Sponsored by Biruni University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled Dec 2021, registered May 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

This is a randomized controlled experimental study to determine the effect of pelvic floor muscle exercise on sexual life.

The study included 64 women admitted to the Erzurum City Hospital, who consented to participate. They were divided into intervention ond control groups (n=32). Pelvic Floor Muscle Exercise *PFME* was applied to the intervention group for 6 weeks with the Simplex Device accompanied by biofeedback in accordance with the PFME application procedure. The control group received routine care.

Read the detailed description

This is a randomized controlled experimental study . The research was carried out in the Erzurum City Hospital. This study, which was conducted to examine the effect of pelvic floor muscle exercises *PFME* on sexual life in women with overactive bladder *OAB* , was conducted with 64 women (32 women: control group, 32 women: intervention group) who applied to the Erzurum City Hospital Urology Polyclinic between December 1, 2021 and December 1, 2024.

Research Hypotheses:

H1: Overactive bladder symptoms are positively affected in women with OAB who perform pelvic floor exercises.

H2: Sexual function is positively affected in women with OAB who perform pelvic floor exercises.

H3: Depression symptoms are positively affected in women with OAB who perform pelvic floor exercises.

H4: Sexual quality of life is positively affected in women with OAB who perform pelvic floor exercises.

H5: Pelvic muscle strength increases in women with OAB who undergo pelvic floor muscle training.

H6: The contraction, relaxation, and percentage of maximum voluntary contraction *MVC* % of pelvic floor muscles improve in women with OAB who undergo pelvic floor muscle training.

Implementation:

The intervention group performed a pelvic floor muscle exercise program in addition to the pharmacological treatment routinely provided at the hospital. Pelvic floor muscle exercises-including identifying the correct muscle, contraction, and relaxation-were taught by the researcher using biofeedback via the Simplex device. The training was reinforced through the use of biofeedback techniques, including a game integrated into the Simplex software, as well as verbal cues provided by the researcher .

To ensure proper continuation of the exercises and to help participants remember them, a handbook prepared by the researcher was provided (Pelvic Floor Muscle Exercise Training Handbook for Women with Overactive Bladder). Participants were asked to complete the Pelvic Floor Muscle Exercise Practice Tracking Form after each exercise session.

Additionally, the women were contacted weekly by the researcher via telephone. They were either invited to the hospital for follow-up or visited at home for evaluation and feedback.

Pelvic Floor Muscle Exercise Program

Week 1:

Contract the pelvic floor muscles for 6 seconds, then relax for 6 seconds. Repeat 25 times. Perform 3 sessions per day (total of 75 contractions per day).

Week 2:

Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day).

Week 3:

Contract for 6 seconds, relax for 6 seconds. Repeat 75 times. Perform 3 sessions per day (total of 225 contractions per day).

Weeks 4-24:

Contract for 6 seconds, relax for 6 seconds. Repeat 100 times. Perform 3 sessions per day (total of 300 contractions per day).

After Week 24:

Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day).

Alternatively (preferred option):

Contract for 6 seconds, relax for 6 seconds. Repeat 75 times. Perform 2 sessions per day (total of 150 contractions per day).

Women in the control group did not receive any intervention or pelvic floor muscle exercise training.

02

Conditions studied

  • Sexual Function
  • Over Active Bladder

Keywords

  • over active bladder
  • Pelvic Floor Muscle
  • sexual function
03

In context

Lead sponsor

Biruni University is the lead sponsor of 172 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Being between 18 and 70 years of age
  • Speaking Turkish
  • Being literate
  • Having a diagnosis of Overactive Bladder (OAB)
  • Currently receiving pharmacological treatment for OAB
  • Being willing to participate in the study voluntarily

Exclusion criteria

Exclusion Criteria:

  • Presence of perceptual impairments or psychiatric disorders that interfere with communication
  • Diagnosis of a neurological disease
  • Presence of neuropathy due to Diabetes Mellitus
  • Pelvic organ prolapse at Stage 2 or higher
  • History of anti-incontinence surgery
  • Being pregnant
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • No intervention
    Control

    Women in the control group did not receive any intervention or pelvic floor muscle exercise training.

  • Experimental
    Intervention

    The intervention group performed a pelvic floor muscle exercise program in addition to the pharmacological treatment routinely provided at the hospital. Pelvic Floor Muscle Exercise Program Week 1: Contract the pelvic floor muscles for 6 seconds, then relax for 6 seconds. Repeat 25 times. Perform 3 sessions per day (total of 75 contractions per day). Week 2: Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day). Week 3: Contract for 6 seconds, relax for 6 seconds. Repeat 75 times. Perform 3 sessions per day (total of 225 contractions per day). Weeks 4-24: Contract for 6 seconds, relax for 6 seconds. Repeat 100 times. Perform 3 sessions per day (total of 300 contractions per day). After Week 24: Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day).

    Behavioral: Exercise

Interventions

  • BehavioralExercise

    Pelvic Floor Muscle Exercise Program Week 1: Contract the pelvic floor muscles for 6 seconds, then relax for 6 seconds. Repeat 25 times. Perform 3 sessions per day (total of 75 contractions per day). Week 2: Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day). Week 3: Contract for 6 seconds, relax for 6 seconds. Repeat 75 times. Perform 3 sessions per day (total of 225 contractions per day). Weeks 4-24: Contract for 6 seconds, relax for 6 seconds. Repeat 100 times. Perform 3 sessions per day (total of 300 contractions per day). After Week 24: Contract for 6 seconds, relax for 6 seconds. Repeat 50 times. Perform 3 sessions per day (total of 150 contractions per day).

06

What researchers measure

Primary outcomes

  1. Over active bladder questionnaire

    This questionnaires evaluates urination frequency, sudden feeling of urgency, nocturia, urge type incontinence symptoms. It consists of 8 questions that patients can rate the severity of their complaints as none (0); very little (1); a little (2); quite a bit (3); a lot (4); and very much (5).

    Time frame: Change from beginning of the study and after 6th week of exercise program

  2. pelvic floor muscle contraction strength

    Pelvic floor muscle strength measurement by digital palpation

    Time frame: Change from beginning of the study and after 6th week of exercise program

  3. pelvic floor muscle contraction strength

    Pelvic floor muscle strength measurement by Simplex device

    Time frame: Change from beginning of the study and after 6th week of exercise program

  4. pelvic floor muscle relaxation strength

    Pelvic floor muscle strength measurement by Simplex device

    Time frame: Change from beginning of the study and after 6th week of exercise program

  5. Female Sexual Function Index Scores ≤ 26.55

    The Female Sexual Function Index consists of 19 items that measure six domains of female sexual function: Desire (2 items) Arousal (4 items) Lubrication (4 items) Orgasm (3 items) Satisfaction (3 items) Pain (3 items; includes discomfort during or after vaginal penetration) Each item is scored on a Likert-type scale, typically ranging from 0 or 1 to 5.Total score range: 2.0 to 36.0 Cut-off score: A total FSFI score of ≤26.55 is commonly used to indicate female sexual dysfunction (FSD).

    Time frame: Change from beginning of the study and after 6th week of exercises program

  6. Center of Epidemiologic Studies Depression Scale

    The Center of Epidemiologic Studies Depression Scale is designed to assess the frequency and severity of symptoms associated with depression. The original CES-D contains 20 items.Each item is scored on a 4-point Likert scale: 0 = Rarely or none of the time (\<1 day) 1. = Some or a little of the time (1-2 days) 2. = Occasionally or a moderate amount of time (3-4 days) 3. = Most or all of the time (5-7 days) Total scores range from 0 to 60. A score of 16 or higher is generally used as a cut-off to indicate significant levels of depressive symptoms, though this is not a diagnostic tool.

    Time frame: Change from beginning of the study and after 6th week of exercise program.

07

Study locations

1 site
  • Biruni Üniversitesi
    Istanbul, Zeytinburnu 34051, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — The investigators did not obtain permission from the participants to share their data with other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07030608
Lead sponsor
Biruni University
Responsible party
Nezihe KIZILKAYA BEJI (Professor, Biruni University) — Principal investigator
First posted
Jun 22, 2025
Start date
Dec 1, 2021
Primary completion
Dec 1, 2024
Completion
Mar 1, 2025
Last update
Aug 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion